Interactive Transcript
0:00
The following vignette will showcase a patient
0:04
who has cirrhosis, with several nodules
0:07
in the liver, um, and it'll, we'll use it
0:10
as an opportunity to talk a little bit more
0:12
about some of the non-malignant nodules that
0:13
we can see in patients who have cirrhosis.
0:16
So here's our patient,
0:17
a 7-year-old male who's being screened
0:18
for hepatocellular carcinoma.
0:20
Over here we have a T2-weighted sequence.
0:23
Here we have a T1-weighted
0:24
sequence with fat saturation.
0:26
And we're going to focus on this nodule here.
0:30
The lateral left hepatic lobe.
0:32
Now, as has been mentioned previously,
0:34
with cirrhosis, there's chronic
0:36
inflammation, the liver parenchyma gets
0:38
destroyed, and then the liver tries to
0:39
regenerate some of that lost parenchyma.
0:42
And it does this, yielding
0:43
these regenerative nodules.
0:45
And they're composed generally
0:46
of normal liver cells.
0:48
But in addition to these regenerative
0:49
nodules, you can also develop
0:52
something called dysplastic nodules.
0:55
Now, dysplastic nodules will harbor
0:58
histologically abnormal cells.
1:00
They can have a variety of imaging
1:02
appearances, but in general, on the
1:03
T2-weighted imaging, they're going to
1:05
be lower in signal or hypointense.
1:08
On the T1-weighted imaging, they're going to
1:10
be hyperintense, as can be seen over here.
1:13
And when we give contrast, again, as can be seen
1:15
on this T1-weighted image with fat saturation,
1:18
post-contrast arterial phase, this is in the
1:21
portal venous phase, this lesion over here,
1:24
Generally, it demonstrates enhancement that is
1:27
similar to the liver or less than the liver.
1:32
There won't be any arterial hyperenhancement
1:37
associated with these dysplastic nodules.
1:39
Now it is thought that these dysplastic nodules
1:42
undergo various degrees of differentiation.
1:45
As a result, their imaging appearance can
1:48
change, so they can go from low-grade dysplastic
1:51
nodules to high-grade dysplastic nodules.
1:53
And in the following vignette, we're
1:55
going to showcase how some of these
1:57
changes look like on MR imaging.
© 2024 Medality. All Rights Reserved.